GlassScriptPhysician profile
David R Lopez
NPI 1568472058
$3,165.78
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $196 · 2021: $28.55 · 2023: $259 · 2024: $2,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,129 · Entertainment: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.89 |
| Entertainment | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $1,000.00 | 2024 | |
| Optos, INC. | $385.06 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $379.50 | 2019-2024 | Total30 |
| Sun Pharmaceutical Industries INC. | $240.04 | 2023-2024 | Cequa |
| Carl Zeiss Meditec USA, INC. | $161.60 | 2024 | Cirrus Hd-Oct |
| Bausch & Lomb Americas INC. | $140.87 | 2023-2024 | Miebo, Infuse |
| Novartis Pharmaceuticals Corporation | $125.00 | 2020 | |
| Lkc Technologies, INC. | $119.20 | 2023 | |
| Dompe US, INC. | $116.74 | 2024 | Oxervate |
| Biotissue Holdings INC. | $103.83 | 2024 | |
| Quidel Corporation | $97.55 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $94.25 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.12 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $35.85 | 2019-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $17.49 | 2019 | |
| Indivior INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.